NCT00574496 Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00574392 Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo Status COMPLETED Phase N/A
NCT00574353 Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients Status COMPLETED Phase NA
NCT00573833 Internal Radiation Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase NA
NCT00570401 Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib Status COMPLETED Phase PHASE2
NCT00567229 Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma Status TERMINATED Phase PHASE2
NCT00562640 Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) Status COMPLETED Phase PHASE1
NCT00561756 Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT00550628 Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer Status COMPLETED Phase N/A
NCT00546377 Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00541034 Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00539643 Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00536874 Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00530049 Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure Status COMPLETED Phase N/A
NCT00528450 Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia Status TERMINATED Phase PHASE2
NCT00526292 Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT00522301 Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission Status TERMINATED Phase PHASE2
NCT00521014 GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2